Artigos recentes
- Adapting COVID-19 vaccines to SARS-CoV-2 variants: guidance for vaccine manufacturers
- CLINICAL TRIALS REGULATION:(EU) Nr. 536/2014.
- EMA has published the EU IDMP Implementation Guide version 2.0
- Guideline on good pharmacovigilance practices (GVP) 4 Module XVI – Risk minimisation measures: selection of tools and 5 effectiveness indicators (Rev 3)
- EUDAMED NEWS: management of legacy devices.
- GUIDANCE ON THE MANAGEMENT OF CLINICAL TRIALS DURING THE COVID-19 (CORONAVIRUS) PANDEMIC vs 4 : KEY CHANGES
- GVP: EMA revised risk minimization module
- Veterinary Medicinal Products Regulation HIGHLIGHTS